Bill Shingleton is an accomplished R&D Director in Cell Therapy at Cytiva, with over 20 years of research experience spanning the medical, academic, biotech, and consumer goods sectors. They have successfully managed large teams to deliver innovative products and therapies aimed at improving well-being. Shingleton's expertise includes conducting research in therapeutic areas such as oncology and rheumatology, and they possess a proven track record in analyzing technology options and accelerating them to market. They earned a BSc (Hons) in Applied Biological Sciences from Bristol Polytechnic and a PhD in Equine Joint Disease from the University of Cambridge.
This person is not in the org chart
This person is not in any teams
This person is not in any offices